加载中
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
前收盘价
US$2.11
US$0.00 · 0.00%
盘中时间采用ET。市场数据可能有所延迟。
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
日内区间
当前US$2.11
52周区间
当前US$2.11
盘中时间采用ET。市场数据可能有所延迟。
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
日内区间
当前US$2.11
52周区间
当前US$2.11
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 101.8万 USD | 124.6万 USD | 262.7万 USD | 60.1万 USD | 60.6万 USD |
| 销货成本 | 121.9万 USD | 81.1万 USD | 78.4万 USD | 26.5万 USD | 44.9万 USD |
| 毛利 | −20.1万 USD | 43.5万 USD | 184.3万 USD | 33.6万 USD | 15.7万 USD |
| 研究与开发 | 458.7万 USD | 520.1万 USD | 871.3万 USD | 645万 USD | 588.6万 USD |
| 销售、一般及管理费用 | 643.9万 USD | 461.1万 USD | 535.9万 USD | 532.6万 USD | 489.1万 USD |
| 营业费用 | 1052万 USD | 1448.2万 USD | 1520.1万 USD | 1167.1万 USD | 1077.7万 USD |
| 利息收入 | 17.5万 USD | 10.7万 USD | 13.5万 USD | 2.3万 USD | 10.1万 USD |
| 利息支出 | 5.2万 USD | 2.9万 USD | 2000 USD | 1.7万 USD | 2.5万 USD |
| 折旧和摊销 | 66.2万 USD | 138.4万 USD | 165.7万 USD | 96.3万 USD | 65万 USD |
| 营业利润 | −1072.1万 USD | −1404.7万 USD | −1335.8万 USD | −1133.5万 USD | −1062万 USD |
| 净利润 | −1708.3万 USD | −1102.4万 USD | −825.9万 USD | −1203.9万 USD | −930.9万 USD |
公司数据更新于 2026年10月11日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
